Supraventricular Tachycardia

• FDA label_change · 2025-04-16
  FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)

  FDA approves a supplemental application for Cardizem CD (diltiazem hydrochloride) by Bausch Health US LLC.

• FDA label_change · 2016-06-29
  FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)

  FDA has approved a supplemental application for Cardizem CD (diltiazem hydrochloride) filed by Bausch Health US LLC under NDA 020062.

• FDA label_change · 2016-04-08
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (EXELA PHARMA SCIENCES, LLC)

  FDA approved a supplemental application for verapamil hydrochloride, resulting in changes to its labeling.

• FDA label_change · 2015-03-23
  FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)

  FDA approved a supplemental labeling application for Cardizem LA (diltiazem hydrochloride extended-release tablets) from Bausch Health US LL…